A case of paraneoplastic hypercalcaemic syndrome is reported in a patient with Hodgkin's disease. This was detected eight months before widespread lymphadenopathy became apparent. Lymphocyte depleted Hodgkin's disease was diagnosed. PTH (parathyroid hormone) activity was suppressed and PTHRP (PTH related protein) was less than 5 pmol/l.
range. Plasma calcium values returned to normal after the administration of indomethacin. Thus the pathogenesis of the hypercalcaemia in this patient could be associated with the synthesis of prostaglandins. Case report A 64 year old man was admitted to hospital because hypercalcaemia was detected at routine examination. The serum calcium ranged from 11-2-14 mg/l and remained in this range, with no response to treatment with diuretics. Immunoradiometric assay showed that the parathyroid hormone (PTH) value was suppressed at 10 0 pg/ml (normal range 10 0-65 0 pg/ml). PTHRP measured by radioimmunoassay was under 5-0 pmol/l (reference value: up to 5 0 pmol/l); 1,25 
present in Hodgkin's disease, it is usually associated with extensive skeletal pathology, and occurs later in the course of the disease."6 However, in the case under discussion we have no radiographic evidence of bone infiltration by Hodgkin's disease. The first bone marrow biopsy specimen contained histiocytic granulomas without diagnostic ReedStemnberg cells, and the second one was negative.
Hypercalcaemia has been related to excess production of 1,25(OH)2D3 in lymphoid neoplasms and in sarcoidosis. Calcitriol is probably a regulatory hormone in both progenitor and mature haematolymphoid cells. If so, then its production in Hodgkin's disease, lymphomas, and granulomatous diseases may not be coincidental. Thus similarities among granulomatous diseases, Hodgkin's disease, and non-Hodgkin's lymphomas are seen with respect to this mechanism of hypercalcaemia. and that sarcoidosis may be related to excessive activity of helper T lymphocytes, causing lymphokine activation of monocytes and macrophages, leading to granulomas and local injury.
Karmali et a!9 reported a patient with Hodgkin's disease and hypercalcaemia who was treated with hydrocortisone. The serum 1,25(OH)2D3 decreased rapidly and eventually led to normnocalcaemia. It seems also that the disturbances of the calcium metabolism are similar to those described in sarcoidosis.
The current case was successfully treated with indomethacin for the normalisation of the calcaemia. This agrees with in vitro studies of bone reabsorption activity. According to most of the cases described, Jacobson et alO hypothesised that a large tumour burden is a necessary prerequisite for the appearance of hypercalcaemia in Hodgkin's disease. However, this does not apply to the case under discussion, in which the development of humoral hypercalcaemia preceded the appearance of multiple adenopathy by eight months.
In a recent paper a case of Hodgkin's disease associated with hypercalcaemia was investigated for the presence of PTHRP (PTH related protein) in the patient's plasma and in tissue neither was detected.1'
In our case the appearance of hypercalcaemia was not explained by the presence of 
